The gap between medical marijuana and street pot

The NIDA, through a contract with growers at the University of Mississippi in Oxford, supplies all marijuana used for research purposes in the U.S. The federal agency is “working to expand the amount and variety of the drug available for study,” according to the science site Nature. The problem faced by institutes researching medical marijuana is that “the agency’s most potent strains still fall short of the most powerful street pot.” One irony in research circles is that U.S. citizens in some 23 U.S. states can relatively easily purchase medical marijuana to treat conditions covering the spectrum from cancer pain to anxiety. However, scientists who want to examine these medical issues and conduct research to determine whether or not marijuana is really effective against such a vast spectrum of medical conditions must wade through vast amounts of red tape. Even after this hurdle has been cleared,...

Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.


URL: 
http://www.digitaljournal.com/life/health/the-gap-between-medical-marijuana-and-street-pot/article/429477